Over the past two decades, percutaneous coronary interventionhas revolutionized the treatment of symptomatic coronary arterydisease, sparing countless patients the need for surgical revascularization.This year, up to a million procedures are likely to be performedin North America alone.
The success of percutaneous coronary intervention has been duelargely to an explosion in technology development, with theintroduction of a broad array of balloon catheters, atherectomydevices, lasers, and stents. The impetus for the developmentof such devices has been the occurrence noted soon afterthe introduction of balloon angioplasty of intimal tears,arterial recoil, and . . . [Full Text of this Article]
This article has been cited by other articles:
Wang, C.-H., Li, S.-H., Weisel, R. D., Fedak, P. W. M., Hung, A., Li, R.-K., Rao, V., Hyland, K., Cherng, W.-J., Errett, L., Leclerc, Y., Bonneau, D., Latter, D. A., Verma, S.
(2005). Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury. Am. J. Physiol. Regul. Integr. Comp. Physiol.
289: R299-R304
[Abstract][Full Text]
Wientgen, H., Thorngate, F. E., Omerhodzic, S., Rolnitzky, L., Fallon, J. T., Williams, D. L., Fisher, E. A.
(2004). Subphysiologic Apolipoprotein E (ApoE) Plasma Levels Inhibit Neointimal Formation After Arterial Injury in ApoE-Deficient Mice. Arterioscler. Thromb. Vasc. Bio.
24: 1460-1465
[Abstract][Full Text]
Schnyder, G., Roffi, M., Flammer, Y., Pin, R., Hess, O. M.
(2002). Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial. JAMA
288: 973-979
[Abstract][Full Text]